+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Onychomycosis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • PDF Icon

    Report

  • 178 Pages
  • May 2025
  • Region: Global
  • Acute Market Reports
  • ID: 6108585
Description Jump to:
The onychomycosis treatment market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.0% from 2025 to 2033, driven by the rising incidence of fungal nail infections, growing aging population, increasing diabetes prevalence, and expanding demand for aesthetic foot care solutions. Onychomycosis, a fungal infection affecting toenails and fingernails, is increasingly being recognized as a medical and cosmetic concern, resulting in heightened demand for timely diagnosis and effective treatment interventions. Advancements in topical drug formulations, laser therapies, and patient-friendly treatment regimens are reshaping the treatment landscape.

Market Drivers

Increasing Prevalence of Onychomycosis and Comorbidities

The global prevalence of onychomycosis is growing, especially among geriatric populations, diabetic patients, and immunocompromised individuals. The infection is often associated with reduced mobility, pain, and social stigma. High recurrence rates and increasing awareness around foot hygiene have led to higher diagnosis and treatment rates, boosting the demand for antifungal therapies.

Technological Advancements in Laser Therapy

Innovations in laser and photodynamic treatment technologies have enabled non-invasive and time-efficient solutions with high efficacy. These modalities offer targeted treatment with minimal side effects, making them increasingly popular in clinical and aesthetic settings. Moreover, the integration of these technologies in dermatology clinics and medispas is expanding access to non-pharmacological treatment options.

Rising Focus on Aesthetic Dermatology

The growing popularity of aesthetic foot and nail care is contributing to higher demand for onychomycosis treatments, particularly in urban centers. Patients are opting for early-stage interventions to restore nail appearance, especially with improved availability of cosmetically elegant topical antifungals and safer systemic drugs.

Market Restraint

Prolonged Treatment Duration and Recurrence

Onychomycosis treatments often require long-term therapy lasting several months, particularly in severe or chronic cases. Additionally, high recurrence rates especially in toenails can result in patient dissatisfaction and treatment discontinuation. This limits market growth, particularly in cost-sensitive or non-adherent patient groups.

Market Segmentation by Treatment Type

The Treatment Type segment includes Drugs, Laser and Photodynamic Therapy, and Surgery. In 2024, Drugs dominated the market in revenue terms, owing to widespread availability of topical and oral antifungals such as terbinafine, itraconazole, and efinaconazole. These drugs remain the first line of treatment across primary care and dermatology practices. However, Laser and Photodynamic Therapy is expected to witness the highest growth through 2033, driven by increasing preference for non-invasive methods, fewer systemic side effects, and better patient compliance. Surgical interventions are typically reserved for severe or unresponsive cases and account for a niche share of the overall market.

Market Segmentation by Disease Type

The Disease Type segment comprises Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, and Other Disease Types.
Distal Subungual Onychomycosis (DSO) represented the largest revenue share in 2024, as it is the most common form of fungal nail infection, affecting both fingernails and toenails. White Superficial Onychomycosis (WSO) and Proximal Subungual Onychomycosis (PSO) are less prevalent but are increasingly diagnosed due to improved clinical awareness. Other disease types, including candidal infections and total dystrophic onychomycosis, make up a smaller yet significant segment and are often seen in immunocompromised or elderly populations.

Geographic Trends

Geographically, North America led the market in 2024 in terms of revenue, supported by high awareness levels, strong healthcare infrastructure, and access to advanced dermatological treatments in the U.S. and Canada. Europe followed closely, particularly in countries like Germany, the UK, France, and Italy where dermatological care is accessible and cosmetic dermatology is well-established. The Asia Pacific region is projected to register the highest CAGR from 2025 to 2033, fueled by rising disposable incomes, growing demand for aesthetic care, and increasing healthcare access in countries such as China, Japan, South Korea, and India. Latin America and Middle East & Africa (MEA) are emerging regions, with growth driven by expanding dermatology clinics, increasing foot health awareness, and broader distribution of antifungal drugs.

Competitive Trends

The onychomycosis treatment market is highly fragmented, with a mix of pharmaceutical manufacturers, dermatology-focused firms, podiatry centers, and aesthetic service providers. In 2024, Pfizer, Novartis, GlaxoSmithKline, and Bausch Health Sciences held strong positions through their antifungal portfolios and global distribution networks. Moberg Pharma, Taro Pharmaceuticals, and Dr. Reddy's Laboratories are active in both branded and generic topical solutions. Kaken Pharmaceuticals and Galderma Laboratories continue to expand in the Japanese and global dermatology segments, with differentiated product offerings. Emerging companies such as Azilda Family Foot Care, Skin Logic Aesthetics, and South Charlotte General and Vascular Surgery are contributing through localized treatment innovations and patient care services. Merz Pharma and Johnson & Johnson Services have strategic interests in dermatology, with potential for expanded participation in antifungal therapies. The market is expected to witness consolidation and innovation through licensing agreements, R&D investments, and integration of digital dermatology platforms for patient engagement and remote diagnosis.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Onychomycosis Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users & consumption volume, price, and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Onychomycosis Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

Market Segmentation

  • Treatment Type
  • Drugs
  • Oral antifungal drugs
  • Topical antifungal drugs
  • Laser and photodynamic therapy
  • Surgery
  • Disease Type
  • Distal subungual onychomycosis
  • Proximal subungual onychomycosis
  • White superficial onychomycosis
  • Other disease types
  • Gender
  • Male
  • Female
  • End Use
  • Hospitals
  • Dermatology clinics
  • Homecare settings
  • Ambulatory surgical centers

Region Segment (2023 - 2033; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Onychomycosis Treatment market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Onychomycosis Treatment market?
  • Which is the largest regional market for Onychomycosis Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Onychomycosis Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Onychomycosis Treatment market worldwide?

This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Onychomycosis Treatment Market
2.2. Global Onychomycosis Treatment Market, By Treatment Type, 2024 (US$ Million)
2.3. Global Onychomycosis Treatment Market, By Disease Type, 2024 (US$ Million)
2.4. Global Onychomycosis Treatment Market, By Gender, 2024 (US$ Million)
2.5. Global Onychomycosis Treatment Market, By End Use, 2024 (US$ Million)
2.6. Global Onychomycosis Treatment Market, By Geography, 2024 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2024
3. Onychomycosis Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Onychomycosis Treatment Market Vendors
3.2. Strategies Adopted by Onychomycosis Treatment Market Vendors
4. Onychomycosis Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Onychomycosis Treatment Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Drugs
5.3.1.1. Oral antifungal drugs
5.3.1.2. Topical antifungal drugsÂ
5.3.2. Laser and photodynamic therapy
5.3.3. Surgery
6. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Distal subungual onychomycosis
6.3.2. Proximal subungual onychomycosis
6.3.3. White superficial onychomycosis
6.3.4. Other disease types
7. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Male
7.3.2. Female
8. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2024 Versus 2033
8.3. Market Segmentation
8.3.1. Hospitals
8.3.2. Dermatology clinics
8.3.3. Homecare settings
8.3.4. Ambulatory surgical centers
9. North America Onychomycosis Treatment Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
9.3. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
9.4. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
9.5. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
9.6. Onychomycosis Treatment Market: By Region, 2023-2033, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
9.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
9.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
9.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
9.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
9.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
9.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
9.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
9.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
9.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10. UK and European Union Onychomycosis Treatment Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.3. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.4. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.5. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10.6. Onychomycosis Treatment Market: By Region, 2023-2033, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.6.1.4.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.6.1.4.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.6.1.4.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10.6.1.5. France
10.6.1.5.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.6.1.5.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.6.1.5.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.6.1.5.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
10.6.1.6.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
10.6.1.6.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
10.6.1.6.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11. Asia Pacific Onychomycosis Treatment Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.3. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.4. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.5. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11.6. Onychomycosis Treatment Market: By Region, 2023-2033, USD (Million)
11.6.1. Asia Pacific
11.6.1.1. China
11.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11.6.1.3. India
11.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.6.1.4.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.6.1.4.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.6.1.4.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.6.1.5.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.6.1.5.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.6.1.5.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
11.6.1.6.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
11.6.1.6.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
11.6.1.6.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
12. Latin America Onychomycosis Treatment Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
12.3. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
12.4. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
12.5. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
12.6. Onychomycosis Treatment Market: By Region, 2023-2033, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
12.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
12.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
12.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
12.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
12.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
12.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
12.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
12.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
12.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
13. Middle East and Africa Onychomycosis Treatment Market, 2023-2033, USD (Million)
13.1. Market Overview
13.2. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
13.3. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
13.4. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
13.5. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
13.6. Onychomycosis Treatment Market: By Region, 2023-2033, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
13.6.1.1.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
13.6.1.1.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
13.6.1.1.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
13.6.1.2.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
13.6.1.2.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
13.6.1.2.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Onychomycosis Treatment Market: By Treatment Type, 2023-2033, USD (Million)
13.6.1.3.2. Onychomycosis Treatment Market: By Disease Type, 2023-2033, USD (Million)
13.6.1.3.3. Onychomycosis Treatment Market: By Gender, 2023-2033, USD (Million)
13.6.1.3.4. Onychomycosis Treatment Market: By End Use, 2023-2033, USD (Million)
14. Company Profile
14.1. Azilda Family Foot Care (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
14.2. Bausch Health Sciences
14.3. Dr. Reddy's Laboratories
14.4. Galderma Laboratories
14.5. GlaxoSmithKline
14.6. Johnson & Johnson Services
14.7. Kaken Pharmaceuticals
14.8. Merz Pharma
14.9. Moberg Pharma
14.10. Novartis
14.11. Pfizer
14.12. Skin Logic Aesthetics
14.13. South Charlotte General and Vascular Surgery
14.14. Other Notable Players
List of Figures
FIG. 1 Global Onychomycosis Treatment Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Onychomycosis Treatment Market: Quality Assurance
FIG. 5 Global Onychomycosis Treatment Market, By Treatment Type, 2024
FIG. 6 Global Onychomycosis Treatment Market, By Disease Type, 2024
FIG. 7 Global Onychomycosis Treatment Market, By Gender, 2024
FIG. 8 Global Onychomycosis Treatment Market, By End Use, 2024
FIG. 9 Global Onychomycosis Treatment Market, By Geography, 2024
FIG. 10 Market Geographical Opportunity Matrix - Global Onychomycosis Treatment Market, 2024
FIG. 11 Market Positioning of Key Onychomycosis Treatment Market Players, 2024
FIG. 12 Global Onychomycosis Treatment Market, By Treatment Type, 2024 Vs 2033, %
FIG. 13 Global Onychomycosis Treatment Market, By Disease Type, 2024 Vs 2033, %
FIG. 14 Global Onychomycosis Treatment Market, By Gender, 2024 Vs 2033, %
FIG. 15 Global Onychomycosis Treatment Market, By End Use, 2024 Vs 2033, %
FIG. 16 U.S. Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 17 Canada Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 18 Rest of North America Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 19 UK Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 20 Germany Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 21 Spain Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 22 Italy Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 23 France Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 24 Rest of Europe Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 25 China Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 26 Japan Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 27 India Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 28 Australia Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 29 South Korea Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 30 Rest of Asia Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 31 Brazil Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 32 Mexico Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 33 Rest of Latin America Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 34 GCC Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 35 Africa Onychomycosis Treatment Market (US$ Million), 2023 - 2033
FIG. 36 Rest of Middle East and Africa Onychomycosis Treatment Market (US$ Million), 2023 - 2033
List of Tables
Table 1 Global Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 2 Global Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 3 Global Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 4 Global Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 5 North America Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 6 North America Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 7 North America Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 8 North America Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 9 U.S. Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 10 U.S. Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 11 U.S. Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 12 U.S. Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 13 Canada Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 14 Canada Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 15 Canada Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 16 Canada Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 17 Rest of North America Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 18 Rest of North America Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 19 Rest of North America Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 20 Rest of North America Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 21 UK and European Union Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 22 UK and European Union Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 23 UK and European Union Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 24 UK and European Union Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 25 UK Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 26 UK Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 27 UK Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 28 UK Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 29 Germany Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 30 Germany Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 31 Germany Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 32 Germany Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 33 Spain Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 34 Spain Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 35 Spain Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 36 Spain Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 37 Italy Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 38 Italy Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 39 Italy Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 40 Italy Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 41 France Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 42 France Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 43 France Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 44 France Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 45 Rest of Europe Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 46 Rest of Europe Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 47 Rest of Europe Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 48 Rest of Europe Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 49 Asia Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 50 Asia Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 51 Asia Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 52 Asia Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 53 China Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 54 China Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 55 China Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 56 China Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 57 Japan Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 58 Japan Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 59 Japan Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 60 Japan Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 61 India Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 62 India Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 63 India Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 64 India Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 65 Australia Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 66 Australia Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 67 Australia Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 68 Australia Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 69 South Korea Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 70 South Korea Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 71 South Korea Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 72 South Korea Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 73 Latin America Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 74 Latin America Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 75 Latin America Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 76 Latin America Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 77 Brazil Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 78 Brazil Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 79 Brazil Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 80 Brazil Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 81 Mexico Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 82 Mexico Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 83 Mexico Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 84 Mexico Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 85 Rest of Latin America Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 86 Rest of Latin America Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 87 Rest of Latin America Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 88 Rest of Latin America Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 89 Middle East and Africa Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 90 Middle East and Africa Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 91 Middle East and Africa Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 92 Middle East and Africa Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 93 GCC Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 94 GCC Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 95 GCC Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 96 GCC Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 97 Africa Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 98 Africa Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 99 Africa Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 100 Africa Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)
Table 101 Rest of Middle East and Africa Onychomycosis Treatment Market By Treatment Type, 2023-2033, USD (Million)
Table 102 Rest of Middle East and Africa Onychomycosis Treatment Market By Disease Type, 2023-2033, USD (Million)
Table 103 Rest of Middle East and Africa Onychomycosis Treatment Market By Gender, 2023-2033, USD (Million)
Table 104 Rest of Middle East and Africa Onychomycosis Treatment Market By End Use, 2023-2033, USD (Million)

Companies Mentioned

  • Azilda Family Foot Care
  • Bausch Health Sciences
  • Dr. Reddy's Laboratories
  • Galderma Laboratories
  • GlaxoSmithKline
  • Johnson & Johnson Services
  • Kaken Pharmaceuticals
  • Merz Pharma
  • Moberg Pharma
  • Novartis
  • Pfizer
  • Skin Logic Aesthetics
  • South Charlotte General and Vascular Surgery

Related Topics

Related Reports

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033 - Product Image

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Onychomycosis Treatment Market by Drug Type (Combination Therapy, Laser Therapy, Oral Therapy), Active Ingredient (Amorolfine, Ciclopirox, Efinaconazole), Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast 2025-2030 - Product Image

Onychomycosis Treatment Market by Drug Type (Combination Therapy, Laser Therapy, Oral Therapy), Active Ingredient (Amorolfine, Ciclopirox, Efinaconazole), Formulation, Distribution Channel, Treatment Setting, Age Group, Gender, Disease Severity - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Onychomycosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Onychomycosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 170 Pages
  • Global
From
Onychomycosis Market Report 2025 - Product Image

Onychomycosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.